e-Connect for Suicide Prevention in Youth
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
What data supports the effectiveness of the treatment e-Connect for suicide prevention in youth?
Research shows that telecommunication-based interventions, like text messaging, can help reduce suicidal thoughts and behaviors in youths after hospital discharge. Additionally, using smartphone apps for safety planning and personalized management strategies has been found feasible and acceptable for managing self-harm and suicidal acts in adolescents.12345
Is e-Connect for Suicide Prevention in Youth safe for humans?
The research highlights challenges in defining and reporting adverse events (unwanted side effects) in suicide prevention studies, making it hard to evaluate safety. However, using multiple methods like structured follow-up calls can improve detection of these events, suggesting that careful monitoring is important for safety in such interventions.678910
How is the e-Connect treatment for suicide prevention in youth different from other treatments?
The e-Connect treatment is unique because it likely involves an online or telecommunication-based approach, which can include e-learning modules or online interventions to improve knowledge and self-confidence in recognizing and addressing suicidal behavior in youth. This method is distinct from traditional face-to-face therapy by providing accessible, flexible, and potentially anonymous support, which can be particularly appealing to young people who may be hesitant to seek in-person help.511121314
What is the purpose of this trial?
We propose to conduct research on strategies that support the successful scale-up of an evidence-based, suicidal risk and behavior identification and cross-system linkage programs for justice-involved youth (e-Connect), and to rigorously evaluate the implementation activities and associated costs that support that scale-up of e-Connect within 9 Indiana counties. Guided by the GPM and EPIS frameworks, this 4-year study will comprise 3 project phases: (1) Scale-Up Strategy Efforts, focused on preparing for scale-up; (2) e-Connect-scaleup implementation (2a Exploration and Preparation and 2b Implementation and Sustainment); and (3) Scale-Up Effectiveness Trial/Outcome Evaluation. The current project draws on lessons learned from the e-Connect efficacy trial in NYS and research team leadership will serve as External Facilitators to support 9 Local Facilitators to ensure the successful transfer of knowledge, skill and expertise in delivering e-Connect in a new JJ system and geographic context, utilizing implementation strategies to support the more widespread, sustained and rigorous adoption of e-Connect. The study will include a learning community created by External Facilitators for Local Facilitators to provide support, to exchange strategies to handle implementation issues, to develop competencies in facilitation, and to guide implementation throughout the program. The learning community will help Local Facilitators navigate through the implementation stages of the study.
Eligibility Criteria
This trial is for probation agency leadership and officers at least 18 years old who speak English, working in the partnering sites of the study's Indiana counties. There are no specific exclusion criteria or special classes of participants.Inclusion Criteria
Exclusion Criteria
Timeline
Scale-Up Strategy Efforts
Focused on preparing for scale-up of the e-Connect program
e-Connect-scaleup Implementation
Implementation of e-Connect in juvenile probation settings, including Exploration and Preparation, and Implementation and Sustainment
Scale-Up Effectiveness Trial/Outcome Evaluation
Evaluation of the effectiveness of the e-Connect scale-up, including clinical and cost-effectiveness assessments
Follow-up
Participants are monitored for the sustainability and fidelity of the e-Connect implementation
Treatment Details
Interventions
- e-Connect
Find a Clinic Near You
Who Is Running the Clinical Trial?
New York State Psychiatric Institute
Lead Sponsor
Indiana University School of Medicine
Collaborator
Chestnut Health Systems
Collaborator
National Institute of Mental Health (NIMH)
Collaborator
George Mason University
Collaborator
Columbia University
Collaborator